Focal therapy using high-intensity focused ultrasound for localised prostate cancer
In development [GID-IPG10224] Expected publication date: 01 March 2023
Search results
606 results
-
-
Multiple sclerosis in adults: management
In development [GID-NG10153] Expected publication date: 15 June 2022
-
Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and management
In development [GID-NG10149] Expected publication date: 07 December 2023
-
Transperineal biopsy for diagnosing prostate cancer
In development [GID-DG10043] Expected publication date: 22 June 2022
-
Depression in adults: treatment and management (update)
In development [GID-CGWAVE0725] Expected publication date: 29 June 2022
-
Fractures (complex): assessment and management
In development [GID-NG10328] Expected publication date: TBC
-
KardiaMobile 6L for measuring QT interval in people having antipsychotic medication
In development [GID-DG10048] Expected publication date: 08 March 2023
-
Baricitinib for treating severe alopecia areata ID3979
In development [GID-TA10941] Expected publication date: TBC
-
GID-MT563 NPi-200 for pupillary light reflex in critical care patients
In development [GID-MT563] Expected publication date: TBC
-
Melanoma: assessment and management
In development [GID-NG10155] Expected publication date: 27 July 2022
-
Hip fracture: management (update)
In development [GID-NG10280] Expected publication date: 12 October 2022
-
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over [ID3988]
In development [GID-TA10948] Expected publication date: TBC
-
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma [ID3901]
In development [GID-TA10785] Expected publication date: 16 November 2022
-
Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder
In development [GID-IPG10207] Expected publication date: TBC
-
Mosunetuzumab for treating relapsed or refractory follicular lymphoma [ID3931]
In development [GID-TA10816] Expected publication date: 25 January 2023
-
Brolucizumab for treating diabetic macular oedema [ID3902]
In development [GID-TA10794] Expected publication date: 16 November 2022
-
Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia [ID3860]
In development [GID-TA10746] Expected publication date: 01 March 2023
-
Foslevodopa-foscarbidopa for treating Parkinson's disease with motor symptoms [ID3876]
In development [GID-TA10772] Expected publication date: 03 May 2023
-
Artificial intelligence (AI) software to help clinical decision making in stroke
In development [GID-DG10044] Expected publication date: 20 July 2022
-
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (update of DG23)
In development [GID-DG10040] Expected publication date: 20 July 2022
-
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia
In development [GID-IPG10214] Expected publication date: 21 September 2022
-
Removal, preservation and subsequent re-implantation of ovarian tissue to prevent symptoms from the menopause
In development [GID-IPG10170] Expected publication date: 21 September 2022
-
Tirzepatide for treating type 2 diabetes ID3938
In development [GID-TA10835] Expected publication date: TBC
-
Risankizumab for previously treated moderately to severely active Crohn's disease [ID3986]
In development [GID-TA10884] Expected publication date: 08 March 2023
-
Menopause: diagnosis and management
In development [GID-NG10241] Expected publication date: 23 August 2023
-
Sepsis
In development [GID-NG10310] Expected publication date: TBC
-
Cardiovascular disease: risk assessment and reduction, including lipid modification
In development [GID-NG10178] Expected publication date: 19 April 2023
-
Vaccine uptake in the general population
In development [GID-NG10139] Expected publication date: 17 May 2022
-
Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea
In development [GID-IPG10223] Expected publication date: TBC
-
Transcutaneous electrical neuromuscular stimulation for urinary incontinence
In development [GID-IPG10200] Expected publication date: 17 August 2022
-
Diabetes update
In development [GID-NG10152] Expected publication date: TBC
-
Harmful gambling: identification, assessment and management
In development [GID-NG10210] Expected publication date: 07 February 2024
-
Metastatic spinal cord compression in adults: risk assessment, diagnosis and management
In development [GID-NG10185] Expected publication date: 23 August 2023
-
Maralixibat for treating cholestatic disease in Alagille Syndrome ID3941
In development [GID-TA10832] Expected publication date: TBC
-
GID-MT565 Optilume for recurrent bulbar urethral strictures
In development [GID-MT565] Expected publication date: 28 November 2022
-
Olaparib in combination with bevacizumab for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy with bevacizumab [Review of TA693] [ID4066]
In development [GID-TA10978] Expected publication date: TBC
-
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer [Review of TA611] [ID4069]
In development [GID-TA10985] Expected publication date: TBC
-
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]
In development [GID-TA10979] Expected publication date: TBC
-
GID-MT562 FibroScan for assessing liver fibrosis and cirrhosis in primary or community care
In development [GID-MT562] Expected publication date: 01 June 2022
-
Subarachnoid haemorrhage due to ruptured aneurysms
In development [GID-NG10097] Expected publication date: TBC
-
MT443 Sleepio to treat insomnia symptoms
In development [GID-MT552] Expected publication date: 20 May 2022
-
Targeted-release budesonide for treating IgA nephropathy ID1434
In development [GID-TA11028] Expected publication date: TBC
-
Avalglucosidase alfa for treating Pompe disease [ID3737]
In development [GID-TA10876] Expected publication date: 17 August 2022
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642
In development [GID-HST10044] Expected publication date: 25 January 2023
-
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma in people who have received at least 3 prior therapies [ID1442]
In development [GID-TA10672] Expected publication date: TBC
-
Third molars (impacted) - prophylactic removal [ID898]
In development [GID-TAG525] Expected publication date: TBC
-
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma [ID3760]
In development [GID-TA10629] Expected publication date: 19 January 2023
-
Melanoma (metastatic) - talimogene laherparepvec [ID508]
In development [GID-TAG509] Expected publication date: 28 September 2016
-
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
In development [GID-TA10820] Expected publication date: 10 August 2022
-
Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma [ID3795]
In development [GID-TA10645] Expected publication date: 10 August 2022